Deloitte named Corporate Financier of the Year by HealthInvestor for second consecutive year
Deloitte’s Healthcare and Life Sciences Corporate Finance team was named ‘Corporate Financier of the Year’ for the second year in a row at the 2014 HealthInvestor Awards.
This event is firmly established as one of the most prestigious for professionals advising, investing or operating within the independent health sector. This year, the Awards were attended by over 1,200 of the sector's leading figures from across the political and commercial spectrum.
Deloitte won the award for their work on a number of high profile transactions such as the sale of Thornton & Ross to STADA and Health Management to Maximus Inc.The team was also the reporting accountant for the IPO of Cambian Group and supported the Trust Special Administrator with the administration of South London NHS Healthcare Trust - the first NHS Trust to be put into administration.
David Jones, Deloitte Healthcare and Life Sciences Corporate Finance Advisory leader, said “HealthInvestor’s recognition of Deloitte’s market leadership in this sector is significant. Deloitte’s involvement in a number of landmark healthcare transactions this year coupled with our ability to deliver advice across the full breadth of corporate finance transactions is why we’ve been marked out for this prestigious award.”